Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats - Gary-Bobo, M; Elachouri, G; Gallas, J F; Janiak, P; Marini, P; Ravinet-Trillou, C; Chabbert, M; Cruccioli, N; Pfersdorff, C; Roque, C; Arnone, M; Croci, T; Soubrie, P; Oury-Donat, F; Maffrand, J P; Scatton, B; Lacheretz, F; Le Fur, G; Herbert, J M; Bensaid, M (Hepatology, 2007)